Liaison Committee: Third Report

Debate between Lord Grenfell and Lord Walton of Detchant

Monday 26th March 2012 Lords Chamber

[Lord Grenfell]

I am most grateful to noble Lords. I begin by declaring an interest, in particular with reference to recommendation 46 about the reduction in the European Union sub-committee structure by one sub-committee. In 2003, when I had the honour of being chairman of the European Union Committee, I argued very strongly for an extra committee and we obtained one. It was not done lightly. It was done because the volume of draft legislation coming from the European Union was enormous and we did not feel that we were able to cover, in particular, draft directives and other documents in the area of social affairs and education. We therefore asked for the extra committee and we got it.

It seems strange that we are arguing for a reduction in the capacity of the European Union committee structure at a time when national parliaments are being asked—in fact, pressed—by the European Union to take a much more significant role and to be a much more substantial part of the structure of the European Union. This is, therefore, not a good time for us to think about reducing our capacity to meet that very considerable challenge. The noble Lord, Lord Roper, in his excellent letter, in appendix 2 of the report and in his very good statement this afternoon, set out the scale of the burden now borne by the European Union Committee. I am rather disappointed that an amendment on that subject has not been tabled to the Motion.

The noble Lord, Lord Alderdice, said again and again that it was a fact that there were not sufficient resources. One might ask why there are not sufficient resources. That seems to me the nub of the question: what are the causes of the financial constraint? One of them—there are several—and maybe one of the biggest, is the unnecessary inflation of the membership of the House. That is to a very large extent a direct cause of the financial problem.

When we consider the additional cost of a new unit of committee activity—who on earth invented that frightful description of our work?—we are told that the additional marginal cost will be in the region of £225,000. That frightens me. Will the abolition of one of our European Union sub-committees save £225,000? If it does, it will save the equivalent of what seven Members of the House of Lords receive in expenses during the course of a year. There is not much chance at the moment of the number of Peers and the membership of the House being reduced by seven. It is going up all the time by several factors of that. This shows how strangely we approach this question of resources. Having seven fewer Members claiming up to £30,000 a year in legitimate expenses and attendance allowance would pay for the European Union sub-committee and, happily, the sub-committee of the Science and Technology Committee. I was deeply moved and impressed by what the noble Lord, Lord Krebs, and his fellow scientists said about that.

Could we not try to be realistic about this and see it in the proper context of resources? If we had a smaller House, we would have more resources. It stands to reason that if we reduce the number of Members of the House, we will reduce the amount that the Exchequer has to put out to pay to keep them here. Why do we always say that there are no resources yet do not address the question of why? The size of the House is a major contributor to that unfortunate situation.

The House has a worldwide reputation of being one of the most cost-effective second Chambers in the world. Within that, it has a reputation of being probably the best scrutiny Chamber in the world. From my own experience, I can certainly tell noble Lords that in the European Union we have consistently been considered—run close by the French Senate—the most effective Chamber scrutinising draft European legislation. Do we want to lose that capacity? No, we do not, so let us look at ways of keeping it. I beg noble Lords to strongly consider why we are short of resources, to address that issue and not to undermine the huge reputation of the House.

[Lord Walton of Detchant]

My Lords, I shall speak briefly. I have read the report of the Liaison Committee with great care. I think that it was carefully argued. I fully appreciate why, in times of financial constraint, it made the proposals that it did. However, we as a country depend on increasing our income and overcoming our deficit. There can be no question, in my opinion, that the development of science, education and technology will play a vital role in helping us to recover from the deficit state in which we find ourselves. Unfortunately, we are slow to take account of, develop and extend the results of scientific discovery—a problem that we have faced over many years.

We live now in an era of evidence-based and translational medicine—meaning the ability to convert the results of basic science into developments in patient care and new methods of treatment of disease. It is crucial that the results of research in basic science, engineering and technology should do the same. Happily, the Government have put more money into scientific research. The Technology Strategy Board is making a major impact, and so, too, are a huge number of other important developments—but they need development and they need support.

I have been in the House for 23 years. For 15 of those years, I served as a member of your Lordships’ Committee on Science and Technology. I chaired an inquiry some years ago into research in the National Health Service. That was a privilege. The report of that sub-committee inquiry led to the Culyer report and then the Cooksey report, and ultimately to the introduction of the NHS research programme—and now the highly effective National Institute for Health Research.

I worked on a small inquiry of the sub-committee which, curiously, in a limited field, dealt with the medicinal uses of cannabis and led eventually to the development of a standardised product of cannabis leaf that is now being sold across the world—used for absorption through the mucus membrane of the mouth—and that brings in money from across the world because of its effect in the treatment of multiple sclerosis. I could quote a lot of other inquiries that have been crucial: not least, for instance, the committee I chaired into complementary and alternative medicine, to try to bring a rational basis to the study of this particular area, in which a large amount of money is spent by very many people in this country. That report was taken on board by the National Institutes of Health in the United States as the basis for a programme of research on which it embarked, and into which it put money, to try to get an evidence base for that field of complementary medicine. I could quote many other examples—and many other examples have been quoted today.

The reason I support the amendment tabled by my noble friend Lord Krebs is that the reports of the Science and Technology Committee in this House have not only had a major influence on government policy across the entire scientific field but have won the respect of Britain’s scientific community. Above all, they have won the respect of the international scientific community. As the noble Lord, Lord Jenkin, said, the report on science and society was widely commended in the United States media. I could quote a huge number of other reports from the committee that have had a similar effect.

It is absolutely crucial that the committee should continue to function in its present capacity. My noble friend Lord Krebs said, in his carefully argued and detailed letter in annexe 3 to the third report from the Liaison Committee, proposed,

“wider involvement of members in the committee activity of the House whilst preserving the advantages of a sessional committee”.

He proposed a number of methods for co-opting members to each of the sub-committees and made it clear that he could continue with the two sub-committees of the science committee with co-opted members, increasing the involvement of other Members of the House.

It would be a sad day if that committee, which has fulfilled such a vital role in Britain’s science community, and which has received such outstanding credit from across the world, were to lose one of its sub-committees at a time when Britain needs much more development in science, engineering and technology. For that reason, I strongly support my noble friend Lord Krebs.